ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Senate Appropriations Report Language On NCI, NIH Budgets

September 20, 1996

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

NCI says SELECT study is close to full enrollment.

April 23, 2004

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991